Venmax Drugs and Pharmaceuticals Ltd (NSE: VENMAX), ISIN INE154G01022 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
VENMAX last traded at ₹18.84 (+5.31%), with a 52-week range of ₹15.56 to ₹36.96 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 15.14%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 59/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.